Healthcare professionals and researchers are raising concerns about the growing trend of self-injection practices and their associated health consequences. NHS endocrinologist Dr Bonnie Grant, criminologist Dr Luke Turnock from the University of Lincoln, and Jon Findlay, Harm Reduction Lead at Waythrough, have documented cases where self-injecting has resulted in hospitalizations. The issue is being observed across multiple settings, including hospital wards, needle exchange facilities, and online communities where these practices are discussed.
In separate medical research developments, scientists have made progress in understanding pregnancy-related complications. Researchers have identified a protein that offers significant insight into pre-eclampsia and fetal growth restriction, two conditions recognized as major causes of stillbirth and serious health risks for pregnant women. Dr Gordon Smith, head of the department of Obstetrics and Gynaecology at Cambridge University, contributed to this discovery, which involved identifying a previously overlooked protein. The breakthrough could potentially assist millions of women annually by improving the ability to predict these serious conditions.
Additionally, developments in pharmaceutical manufacturing have attracted attention. British company BioOrbit successfully completed a project involving a miniature drugs factory aboard the International Space Station, where it manufactured crystals for cancer antibody treatments. The initiative has prompted discussion about whether space-based pharmaceutical manufacturing could become integrated into routine medical practice in coming years.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI